Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease
- PMID: 16406150
- DOI: 10.1016/j.neures.2005.11.009
Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease
Abstract
Development of neurofibrillary tangles (NFTs) is a pathological hallmark in various neurodegenerative disorders including Alzheimer's disease (AD). Recently, we identified a granular tau oligomer having a pre-filamentous structure. To determine the role of this oligomer in NFT formation, we quantified the amount of granular tau oligomer in 21 frontal cortex samples, each displaying varying degrees of Braak-staged NFT pathology. Here we report that granular tau oligomer levels in frontal cortex were significantly increased, even in brains displaying Braak-stage I neuropathology, a stage at which clinical symptoms of AD and NFTs in frontal cortex are believed to be absent. This suggests that increases in granular tau oligomer levels occur before NFTs form and before individuals manifest clinical symptoms of AD. Increased granular tau oligomer levels, therefore, may lead to NFT formation in frontal cortex, eventually leading to the development of AD. Thus, increases in granular tau oligomer levels may represent a very early sign of NFT formation and AD.
Similar articles
-
Granular tau oligomers as intermediates of tau filaments.Biochemistry. 2007 Mar 27;46(12):3856-61. doi: 10.1021/bi061359o. Epub 2007 Mar 6. Biochemistry. 2007. PMID: 17338548
-
[Drug development for tauopathy and Alzheimer's disease].Nihon Shinkei Seishin Yakurigaku Zasshi. 2010 Aug;30(4):177-80. Nihon Shinkei Seishin Yakurigaku Zasshi. 2010. PMID: 20857696 Review. Japanese.
-
[Significance of tau in the development of Alzheimer's disease].Brain Nerve. 2010 Jul;62(7):701-8. Brain Nerve. 2010. PMID: 20675874 Review. Japanese.
-
Molecular chaperone-mediated tau protein metabolism counteracts the formation of granular tau oligomers in human brain.J Neurosci Res. 2007 Nov 1;85(14):3098-108. doi: 10.1002/jnr.21417. J Neurosci Res. 2007. PMID: 17628496
-
Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).Lab Invest. 1992 Feb;66(2):212-22. Lab Invest. 1992. PMID: 1735956
Cited by
-
Understanding the Pathophysiological Actions of Tau Oligomers: A Critical Review of Current Electrophysiological Approaches.Front Mol Neurosci. 2020 Aug 20;13:155. doi: 10.3389/fnmol.2020.00155. eCollection 2020. Front Mol Neurosci. 2020. PMID: 32973448 Free PMC article. Review.
-
Extensive p-tau pathology and SDS-stable p-tau oligomers in Alzheimer's cortical synapses.Brain Pathol. 2012 Nov;22(6):826-33. doi: 10.1111/j.1750-3639.2012.00598.x. Epub 2012 May 23. Brain Pathol. 2012. PMID: 22486774 Free PMC article.
-
Identification of oligomers at early stages of tau aggregation in Alzheimer's disease.FASEB J. 2012 May;26(5):1946-59. doi: 10.1096/fj.11-199851. Epub 2012 Jan 17. FASEB J. 2012. PMID: 22253473 Free PMC article.
-
Path integration deficits are associated with phosphorylated tau accumulation in the entorhinal cortex.Brain Commun. 2024 Feb 12;6(1):fcad359. doi: 10.1093/braincomms/fcad359. eCollection 2024. Brain Commun. 2024. PMID: 38347945 Free PMC article.
-
Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild-type human tau.EMBO J. 2007 Dec 12;26(24):5143-52. doi: 10.1038/sj.emboj.7601917. Epub 2007 Nov 15. EMBO J. 2007. PMID: 18007595 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical